We are delighted to be working with two partner organisations in the delivery of the INSIGHT-AM study. Aerogen Ltd are the suppliers of the vibrating mesh technology, allowing us to use the same nebuliser to reliably deliver our intervention to every participant, whether they are intubated and ventilated or self-ventilating. Partner therapeutics are the supplier of Sargramostim, the recombinant human GM-CSF intervention which serves as the keystone for this study.